Panu Miettinen appointed chief financial officer of Biotie

pharmafile | February 16, 2012 | Appointment | Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen 

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies. 

He will become a member of the Group’s management team and will report to Timo Veromaa, president and chief executive. Panu Miettinen will be based at the company’s headquarters in Turku, Finland.

Zack McNealy, current interim CFO, will resume his prior duties as vice president, finance and administration at the Group’s U.S. subsidiary.

Panu Miettinen, a Finnish native, has extensive expertise in finance, strategy, investor relations, and M&A. Previously Panu was the CFO of Elektrobit Corporation. Before joining Elektrobit Panu was a management consultant at Accenture and KPMG Consulting.

Advertisement

Timo Veromaa, chief executive of Biotie said: “I am very pleased that Panu is joining Biotie’s management team and we look forward to his contributions to the organisation. Panu is an experienced finance executive and his broad expertise from different industries will certainly be beneficial as Biotie becomes a more mature development company.”

Related Content

Lundbeck to file alcoholism pill this year

Lundbeck plans to submit its alcohol dependency treatment for European approval later this year after …

The Gateway to Local Adoption Series

Latest content